Search

Search Constraints

You searched for: Author/Creator Khan, Amber

Search Results

5. P130 Treatment of SLE with the immunoproteasome inhibitor KZR-616: results from the first 4 cohorts of the MISSION study, an open-label phase 1b dose escalation trial. (23rd March 2020)